Crosslinking of the CD69 molecule enhances S100A9 production in activated neutrophils

Microbiology and Immunology

Volumn 51, Issue 1, 2007, Pages 87-98

  Shimada, Sonoko ^a   Nakamura, Manabu ^a   Tanaka, Yasuhiko ^a   Tsutsumi, Kouichiro ^a   Katano, Masayoshi ^a,b   Masuko, Kayo ^a   Yudoh, Kazuo ^a   Koizuka, Izumi ^a   Kato, Tomohiro ^a  

^a ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b LSI MEDIENCE CORPORATION   (Japan)

Author keywords

CD69; Neutrophils; S100A9

Indexed keywords

CD69 ANTIGEN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1BETA; PROTEIN S 100; PROTEIN S 100A9; UNCLASSIFIED DRUG;

ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; CROSS LINKING; CYTOKINE PRODUCTION; ELECTROPHORESIS; HUMAN; HUMAN CELL; NEUTROPHIL; PROTEIN ANALYSIS; PROTEIN DATABASE; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; PROTEOMICS; SIGNAL TRANSDUCTION; UPREGULATION;

EID: 33846465420     PISSN: 03855600     EISSN: 13480421     Source Type: Journal    
DOI: 10.1111/j.1348-0421.2007.tb03878.x     Document Type: Article

References (40)

1. Atzeni, F., Schena, M., Ongari, A.M., Carrabba, M., Bonara, P., Minonzio, F., and Capsoni, F. 2002. Induction of CD69 activation molecule on human neutrophils by GMC-SF, IFN-gamma, and IFN-alpha. Cell. Immunol. 220: 20-29.
2. 2+/GTP sensor in exocytotic secretion. Proc. Natl. Acad. Sci. U.S.A. 93: 10797-10802.
3. Cebrian, M., Yague, E., Rincon, M., Lopez-Botet, M., de Landazuri, M.O., and Sanchez-Madrid, F. 1988. Triggering of T cell proliferation through AIM, an activation inducer molecule expressed on activated human lymphocytes. J. Exp. Med. 168: 1621-1637.
4. Cosulich, M.E., Risso, A., Smilovich, D., Baldissarro, I., Capra, M.C., and Bargellesi, A. 1992. CD69 activation molecule: requirements for its expression on T cells. Pharmacol. Res. 26 (Suppl 2): 136-138.
5. De Maria, R., Cifone, M.G., Trotta, R., Rippo, M.R., Festuccia, C., Santoni, A., and Testi, R. 1994. Triggering of human monocyte activation through CD69, a member of the natural killer cell gene complex of signal transducing receptors. J. Exp. Med. 180: 1999-2004.
6. Drynda, S., Ringel, B., Kekow, M., Kuhne, C., Drynda, A., Glocker, M.O., Thiesen, H.J., and Kekow, J. 2004. Proteome analysis reveals disease-associated marker proteins to differentiate RA patients from other inflammatory joint diseases with the potential to monitor anti-TNFalpha therapy. Pathol. Res. Pract. 200: 165-171.
7. Ellgaard, L., and Ruddock, L.W. 2005. The human protein disulphide isomerase family: substrate interactions and functional properties. EMBO Rep. 6: 28-32.
8. Foell, D., and Roth, J. 2004. Proinflammatory S100 proteins in arthritis and autoimmune disease (review). Arthritis Rheum. 50: 3762-3771.
9. Frosch, M., Strey, A., Vogl, T., Wulffraat, N.M., Kuis, W., Sunderkotter, C., Harms, E., Sorg, C., and Roth, J. 2000. Myeloid-related proteins 8 and 14 are specifically secreted during interaction of phagocytes and activated endothelium and are useful markers for monitoring disease activity in pauciarticular-onset juvenile rheumatoid arthritis. Arthritis Rheum. 43: 628-637.
10. Frosch, M., Vogl, T., Seeliger, S., Wulffraat, N., Kuis, W., Viemann, D., Foell, D., Sorg, C., Sunderkotter, C., and Roth, J. 2003. Expression of myeloid-related proteins 8 and 14 in systemic-onset juvenile rheumatoid arthritis. Arthritis Rheum. 48: 2622-2626.
11. Gavioli, R., Risso, A., Smilovich, D., Baldissarro, I., Capra, M.C., Bargellesi, A., and Cosulich, M.E. 1992. CD69 molecule in human neutrophils: its expression and role in signal-transducing mechanisms. Cell. Immunol. 142: 186-196.
12. Gerke, V., and Moss, S.E. 2002. Annexins: from structure to function. Physiol. Rev. 82: 331-371.
13. 2+ signalling to membrane dynamics. Nat. Rev. Mol. Cell Biol. 6: 449-461.
14. Gillis, S., and Watson, J. 1980. Biochemical and biological characterization of lymphocyte regulatory molecules. V. Identification of an interleukin 2-producing human leukemia T cell line. J. Exp. Med. 152: 1709-1719.
15. Jessop, C.E., Chakravarthi, S., Watkins, R.H., and Bulleid, N.J. 2004. Oxidative protein folding in the mammalian endoplasmic reticulum. Biochem. Soc. Trans. 32: 655-658.
16. Kinloch, A., Tatzer, V., Wait, R., Peston, D., Lundberg, K., Donatien, P., Moyes, D., Taylor, P.C., and Venables, P.J. 2005. Identification of citrullinated alpha-enolase as a candidate autoantigen in rheumatoid arthritis. Arthritis Res. Ther. 7: R1421-R1429.
17. Kunisada, T., Miyazaki, M., Mihara, K., Gao, C., Kawai, A., Inoue, H., and Namba, M. 1998. A new human chondrosarcoma cell line (OUMS-27) that maintains chondrocytic differentiation. Int. J. Cancer 77: 854-859.
18. Lanier, L.L., Buck, D.W., Rhodes, L., Ding, A., Evans, E., Barney, C., and Phillips, J.H. 1988. Interleukin 2 activation of natural killer cells rapidly induces the expression and phosphorylation of the Leu-23 activation antigen. J. Exp. Med. 167: 1572-1585.
19. Lee, K.H., Chung, H.S., Kim, H.S., Oh, S.H., Ha, M.K., Baik, J.H., Lee, S., and Bang, D. 2003. Human alpha-enolase from endothelial cells as a target antigen of antiendothelial cell antibody in Behcet's disease. Arthritis Rheum. 48: 2025-2035.
20. Liao, H., Wu, J., Kuhn, E., Chin, W., Chang, B., Jones, M.D., O'Neil, S., Clauser, K.R., Karl, J., Hasler, F., Roubenoff, R., Zolg, W., and Guild, B.C. 2004. Use of mass spectrometry to identify protein biomarkers of disease severity in the synovial fluid and serum of patients with rheumatoid arthritis. Arthritis Rheum. 50: 3792-3803.
21. Maruotti, N., Cantatore, F.P., Crivellato, E., Vacca, A., and Ribatti, D. 2006. Angiogenesis in rheumatoid arthritis. Histol. Histopathol. 21: 557-566.
22. Matsui, T., Kurokawa, M., Kobata, T., Oki, S., Azuma, M., Tohma, S., Inoue, T., Yamamoto, K., Nishioka, K., and Kato, T. 1999. Autoantibodies to T cell costimulatory molecules in systemic autoimmune diseases. J. Immunol. 162: 4328-4335.
23. Moodie, F.D., Leaker, B., Cambridge, G., Totty, N.F., and Segal, A.W. 1993. Alpha-enolase: a novel cytosolic autoantigen in ANCA positive vasculitis. Kidney Int. 43: 675-681.
24. Park, J.E., Leedo, H., Lee, J.A., Park, S.G., Kim, N.S., Park, B.C., and Cho, S. 2005. Annexin A3 is a potential angiogenic mediator. Biochem. Biophys. Res. Commun. 337: 1283-1287.
25. Perretti, M., and Gavins, F.N. 2003. Annexin 1: an endogenous anti-inflammatory protein. News Physiol. Sci. 18: 60-61.
26. Sancho, D., Gomez, M., Viedma, F., Esplugues, E., Gordon-Alonso, M., Garcia-Lopez, M.A., de la Fuente, H., Martinez, A.C., Lauzurica, P., and Sanchez-Madrid, F. 2003. CD69 downregulates autoimmune reactivity through active transforming growth factor-beta production in collagen-induced arthritis. J. Clin. Invest. 112: 872-882.
27. Santis, A.G., Campanero, M.R., Alonso, J.L., Tugores, A., Alonso, M.A., Yague, E., Pivel, J.P., and Sanchez-Madrid, F. 1992. Tumor necrosis factor-alpha production induced in T lymphocytes through the AIM/CD69 activation pathway. Eur. J. Immunol. 22: 1253-1259.
28. Schulze zur Wiesch, A., Foell, D., Frosch, M., Vogl, T., Sorg, C., and Roth, J. 2004. Myeloid related proteins MRP8/MRP14 may predict disease flares in juvenile idiopathic arthritis. Clin. Exp. Rheumatol. 22: 368-373.
29. Seaton, B.A., and Dedman, J.R., 1998. Annexins. Biometals 11: 399-404.
30. Segal, A.W., and Jones, O.T. 1980. Rapid incorporation of the human neutrophil plasma membrane cytochrome b into phagocytic vacuoles. Biochem. Biophys. Res. Commun. 92: 710-715.
31. Shibata, F., Miyama, K., Shinoda, F., Mizumoto, J., Takano, K., and Nakagawa, H. 2004. Fibroblast growth-stimulating activity of S100A9 (MRP-14). Eur. J. Biochem. 271: 2137-2143.
32. Shibata, F., Ito, A., Ohkuma, Y., and Mitsui, K. 2005. Mitogenic activity of S100A9 (MRP-14). Biol. Pharm. Bull. 28: 2312-2314.
33. Sunahori, K., Yamamura, M., Yamana, J., Takasugi, K., Kawashima, M., Yamamoto, H., Chazin, W.J., Nakatani, Y., Yui, S., and Makino, H. 2006. The S100A8/A9 heterodimer amplifies proinflammatory cytokine production by macrophages via activation of nuclear factor kappa B and p38 mitogen-activated protein kinase in rheumatoid arthritis. Arthritis Res. Ther. 8: R69.
34. Tanaka, Y., Nakamura, M., Matsui, T., Iizuka, N., Kondo, H., Tohma, S., Masuko, K., Yudoh, K., Nakamura, H., Nishioka, K., Koizuka, I., and Kato, T. 2006. Proteomic surveillance of autoantigens in relapsing polychondritis. Microbiol. Immunol. 50: 117-126.
35. Taylor, P.C., and Sivakumar, B., 2005. Hypoxia and angiogenesis in rheumatoid arthritis. Curr. Opin. Rheumatol. 17: 293-298.
36. Testi, R., Phillips, J.H., and Lanier, L.L. 1989. T cell activation via Leu-23 (CD69). J. Immunol. 143: 1123-1128.
37. Walsh, G.M., Williamson, M.L., Symon, F.A., Willars, G.B., and Wardlaw, A.J. 1996. Ligation of CD69 induces apoptosis and cell death in human eosinophils cultured with granulocyte-macrophage colony-stimulating factor. Blood 87: 2815-2821.
38. Yamazaki, T., Yokoyama, T., Akatsu, H., Tukiyama, T., and Tokiwa, T. 2003. Phenotypic characterization of a human synovial sarcoma cell line, SW982, and its response to dexamethasone. In Vitro Cell. Dev. Biol. Anim. 39: 337-339.
39. Youssef, P., Roth, J., Frosch, M., Costello, P., Fitzgerald, O., Sorg, C., and Bresnihan, B. 1999. Expression of myeloid related proteins (MRP) 8 and 14 and the MRP8/14 heterodimer in rheumatoid arthritis synovial membrane. J. Rheumatol. 26: 2523-2528.
40. Yu, X., Matsui, T., Otsuka, M., Sekine, T., Yamamoto, K., Nishioka, K., and Kato, T. 2001. Anti-CD69 autoantibodies cross-react with low density lipoprotein receptor-related protein 2 in systemic autoimmune diseases. J. Immunol. 166: 1360-1369.